Antibiotics and mental health: The good, the bad and the ugly
Authors:
Open Access
- 12 July 2022
- journal article
- review article
- Published by Wiley in Journal of Internal Medicine
- Vol. 292 (6) , 858-869
Abstract
Antibiotics are recognised as, on occasion, producing psychiatric side effects, most notably depression and anxiety. Apart from antimicrobial activity, antibiotics have multiple off‐target effects. The brain–gut–microbiota axis has multiple sites for off‐target activity, which may produce either positive or negative antibiotic effects. Here we review how antibiotics impact mental health by acting through the brain–gut–microbiota axis. Microbes in the gut influence brain function by acting through the vagus nerve or by altering the production of short‐chain fatty acids or the amino acid tryptophan, the building block of serotonin. Not all antimicrobial actions of antibiotics have a negative impact. The first antidepressant discovered was actually an antibiotic: isoniazid is an antibacterial drug developed for treating tuberculosis. Minocycline, which enters the brain and mediates its effects through microglia, shows antidepressant activity. Some antibiotics bring about a significant decrease in gut microbial diversity, and this is viewed as a risk factor for depression. Other risk factors induced by antibiotics include altered gut barrier function, activation of the hypothalamic–pituitary–adrenal axis, reducing levels of brain‐derived neurotrophic factor or oxytocin and alteration of vagal tone. Although most patients taking antibiotics do not suffer from an iatrogenic psychiatric disorder, some do. As clinicians, we need to keep this in mind. The development of new antibiotics is primarily focused on antibiotic resistance, but efforts should be made to reduce off‐target brain–gut–microbiota effects resulting in mental health problems.Keywords
Funding Information
- Science Foundation Ireland (SFI/12/RC/2273)
This publication has 112 references indexed in Scilit:
- Regulation of the stress response by the gut microbiota: Implications for psychoneuroendocrinologyPsychoneuroendocrinology, 2012
- Minocycline as adjunctive therapy for patients with unipolar psychotic depression: An open-label studyProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2012
- Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerveProceedings of the National Academy of Sciences, 2011
- Moving pictures of the human microbiomeGenome Biology, 2011
- Treat Your Bug RightFrontiers in Physiology, 2011
- A human gut microbial gene catalogue established by metagenomic sequencingNature, 2010
- Bacterial Community Variation in Human Body Habitats Across Space and TimeScience, 2009
- Metagenomic Analysis of the Human Distal Gut MicrobiomeScience, 2006
- Chronic treatment with fluoxetine up-regulates cellular BDNF mRNA expression in rat dopaminergic regionsInternational Journal of Neuropsychopharmacology, 2005
- Influence of Ampicillin, Clindamycin, and Metronidazole on Faecal Excretion of Short-Chain Fatty Acids in Healthy SubjectsScandinavian Journal of Gastroenterology, 1986